Please wait...

Learn

Finding accredited CPD

New developments in diabetes management - Professor David Story

Description

In this seminar, Professor David Story talks about the new diabetes medications causing increased challenges to care for patients with diabetes and presenting important uncertainties to practitioners.

Learning Outcomes

  1. Recognise the challenges, risks and benefits that the new diabetes drugs present to practitioners and patients. These drugs are: 
    • Glucagon-Like Peptide 1 Receptor Agonists (GLP-1 agonists) - semaglutide (Ozempic) 
    • Sodium-Glucose Cotransporter Type 2 inhibitors (SGLT2i) - also known as gliflozins
  2.  Appreciate the other applications to non-DM patients
  3.  Understand the challenges these drugs provide in non-elective surgery as evidence is still limited. 

Provided by

CPD Activity Details
Topic
Patient outcomes, Chronic Diseases
CAPE Aspects
Professionalism
Effective Year

Educational Activities (EA) - 0.20

Reviewing Performance (RP) - 0.0

Measuring Outcomes (MO) - 0.0

You have to log in to see the content of this module.

*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)